D. E. Shaw & Co., Inc. Nevro Corp Put Options Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$4.71 - $10.1 $268,470 - $575,700	-57,000 Reduced 53.27%	50,000 $279,000
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $199,796 - $341,109	25,100 Added 30.65%	107,000 $900,000
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $1.11 Million - $1.7 Million	81,900 New	81,900 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $408,500 - $776,700	-10,000 Reduced 59.88%	6,700 $294,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $197,835 - $303,798	-3,300 Reduced 16.5%	16,700 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $3.24 Million - $4.85 Million	-40,000 Reduced 66.67%	20,000 $1.62 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $4.8 Million - $7.84 Million	47,100 Added 365.12%	60,000 $6.98 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $540,771 - $1.11 Million	7,700 Added 148.08%	12,900 $1.29 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $13,891 - $17,714	200 Added 4.0%	5,200 $451,000
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $329,700 - $466,550	5,000	5,000 $345,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.